MSB 8.43% $1.35 mesoblast limited

MSB - key dates to watch for, page-5

  1. 939 Posts.
    lightbulb Created with Sketch. 239
    Not looking to troll, it is a simple group of questions:

    1. When is the expected beginning of the new remestemcel-L study (to get FDA approval)?

    2. How many phases will this study require?

    3. When is the expected completion of the new study?

    4. How long is the process from completion of study to FDA approval/rejection?

    Any other key dates would help
    .

    If you don't want to answer then fine, someone else might know an be willing to share the answer and therefore improve the chances of other(s) buying in.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.